HMGB1 and hyperlipidemia: To begin with, levels of circulating HMGB1 are elevated in patents with hyperlipidaemia, which is a state that is significantly is associated with the development of atherosclerosis, but treatment with atorvastatin reduces HMGB1 concentrations [12].